A Randomized, Double-blind, Placebo-controlled, Phase 2 Study of ZSP1273 in Adults With Acute Uncomplicated Influenza A
Latest Information Update: 17 May 2024
At a glance
- Drugs Onradivir (Primary)
- Indications Influenza A virus infections
- Focus Therapeutic Use
- Sponsors Guangdong Raynovent Biotech
Most Recent Events
- 01 May 2024 Results evaluating the safety and efficacy of three onradivir dosing regimens versus placebo in outpatients with acute uncomplicated influenza A virus infection, published in The Lancet Infectious Diseases
- 02 Jun 2020 Status changed from recruiting to completed.
- 10 Dec 2019 Status changed from not yet recruiting to recruiting.